Cost-effectiveness of eplerenone in patients with systolic heart failure and mild symptoms

@inproceedings{Lee2014CosteffectivenessOE,
  title={Cost-effectiveness of eplerenone in patients with systolic heart failure and mild symptoms},
  author={Dawn Lee and Koo Wilson and Ron L. Akehurst and Martin R Cowie and Fa{\"i}ez Zannad and Henry Krum and Dirk Jan van Veldhuisen and John Terence Vincent and Bertram Pitt and John J V McMurray},
  booktitle={Heart},
  year={2014}
}
AIM In the Eplerenone in Mild Patients Hospitalization and Survival Study in Heart Failure (EMPHASIS-HF), aldosterone blockade with eplerenone decreased mortality and hospitalisation in patients with mild symptoms (New York Heart Association class II) and chronic systolic heart failure (HF). The present study evaluated the cost-effectiveness of eplerenone in the treatment of these patients in the UK and Spain. METHODS AND RESULTS Results from the EMPHASIS-HF trial were used to develop a… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 11 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 28 references

2010 / 11 scottish tariffs for cross boundary fl ow costing

  • J Berg, P Lindgren, R Nieuwlaat
  • British National Formulary 62 Cataolgo de…
  • 2011

Base de conocimiento de costes y precios del sector sanitario

  • L Curtis, J Berg, P Lindgren, R Nieuwlaat
  • British National Formulary 62 Cataolgo de…
  • 2011

Similar Papers

Loading similar papers…